David Solomon — all tracked 13F funds

Holdings and reported values are aggregated from the latest 13F filings of every fund entity managed under this manager.

Embed this top-holdings widget →

Fund Holdings (Q2 2026) Reported value
Goldman Sachs Group 5525 $337.82B

🚩 Holdings Prediction Model (2026-Q2)

Next-quarter Top-10 holdings and weights predicted from historical holdings plus per-stock price/volume (no look-ahead). Shows the prediction and backtest accuracy for the manager's core fund .

Predicted Top 10 — Next Quarter (2026-Q3)

Loading forecast…

Historical backtest (18 quarters): avg precision 80% · recall 80% · F1 80%

Form 4 Insider Transactions

Transaction date Activity Security Shares Price Filing
2026-08-06 Buy Attovia Therapeutics, Inc. 500,000 $17.00 SEC filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 478,498 — SEC filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,134 — SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 76,418 $21.04 SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 6,763 $21.61 SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 100 $21.99 SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 1,163 $22.19 SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 700 $22.07 SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 443 $21.78 SEC filing
2026-08-05 Sell Attovia Therapeutics, Inc. 300 $20.84 SEC filing

Insider transactions (Form 4) →

Why several funds per manager?

The SEC attributes a 13F filing to the management company with investment discretion. Big managers run multiple entities — hedge fund, advisers arm, private-investments vehicle — each filing separately. This page groups them so the manager-level picture is not split across filings. Who must file a 13F →

Where to go next

All fund managers → · Insider Transactions · Star manager new positions → · Browse all tracked funds →